IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,940,642 | +17.5% | 646,295 | +147.5% | 0.03% | -2.9% |
| Q3 2022 | $2,502,000 | -54.6% | 261,134 | -47.7% | 0.04% | -58.8% |
| Q2 2022 | $5,517,000 | +77.3% | 499,770 | +167.5% | 0.08% | +70.0% |
| Q1 2022 | $3,111,000 | -73.7% | 186,864 | -69.8% | 0.05% | -70.4% |
| Q4 2021 | $11,811,000 | +158.1% | 618,703 | +233.4% | 0.17% | +125.3% |
| Q3 2021 | $4,576,000 | -47.9% | 185,552 | -33.1% | 0.08% | -61.5% |
| Q1 2021 | $8,786,000 | +777.7% | 277,523 | +1186.4% | 0.20% | +622.2% |
| Q4 2020 | $1,001,000 | -84.7% | 21,574 | -89.1% | 0.03% | -87.4% |
| Q3 2020 | $6,541,000 | -22.1% | 198,684 | -29.2% | 0.21% | -64.3% |
| Q1 2020 | $8,397,000 | +112.7% | 280,498 | +96.6% | 0.60% | +272.7% |
| Q4 2019 | $3,948,000 | – | 142,641 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |